Home » Topics » Regulatory

Regulatory
RSS

MOXCON study will test the efficacy of SIRAs in treating heart failure

Aug. 27, 1998

SSRI produces significant improvements in patients with social phobia

Aug. 26, 1998

First approval for lamivudine in chronic hepatitis B

Aug. 25, 1998

New indication approved for AmBisome in the U.K.

Aug. 24, 1998

Thymosin alpha 1 receives patent protection for hepatitis C indication

Aug. 24, 1998

Canadian launch announced for Zyban sustained-release tablets

Aug. 21, 1998

Nabi files PLA, ELA for hepatitis B immune globulin

Aug. 21, 1998

CellCept receives European approval for use in heart transplantation

Aug. 20, 1998

FDA okays use of Engerix-B in patients with chronic HCV infection

Aug. 17, 1998

Salofalk approved in Canada for the treatment of Crohn's disease

Aug. 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Sun Pharma to acquire Merck spinoff Organon for $11.75B
BioWorld
Sun Pharmaceuticals Industries Ltd. will pay $11.75 billion cash to acquire Organon & Co. The transaction is expected to close in early 2027. The addition of...